Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer.
about
Vandetanib as a potential new treatment for estrogen receptor-negative breast cancers.Identifying subtype-specific associations between gene expression and DNA methylation profiles in breast cancerEGFR Is Regulated by TFAP2C in Luminal Breast Cancer and Is a Target for Vandetanib.Receptor Tyrosine Kinase Expression Predicts Response to Sunitinib in Breast CancerGenetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients.Targeting of RET oncogene by naphthalene diimide-mediated gene promoter G-quadruplex stabilization exerts anti-tumor activity in oncogene-addicted human medullary thyroid cancer.Targeting the receptor tyrosine kinase RET in combination with aromatase inhibitors in ER positive breast cancer xenografts.Targeting RET-driven cancers: lessons from evolving preclinical and clinical landscapes.Germline ESR2 mutation predisposes to medullary thyroid carcinoma and causes up-regulation of RET expression.RET rearrangements are actionable alterations in breast cancer
P2860
Q27853297-70AF205D-A4BF-42E5-82F1-10ED86A081CCQ33771056-AC8B73B4-8D30-490C-BDF3-9F48B3F6697DQ36665258-10E66135-7922-4FAE-8E49-E17E5E94F9E4Q37214094-136217AE-6913-4FBB-A99F-26B629BCE0D7Q37295706-C00CAAAF-1FF7-4EA3-B2D0-E960608B0FF4Q37580294-6B486AF9-EA5B-4505-86B2-408DAFB570C0Q37697034-AD399D37-04AB-4BEB-BC82-8904B2E91B6DQ47601932-40B0D672-1A50-4C05-B6FD-5FDDE43B43F4Q50227566-E684CDD1-362D-400F-8666-B00515976054Q59136613-FB87EF69-220C-44DC-B7DF-D2C49C144EC7
P2860
Inhibition of RET increases the efficacy of antiestrogen and is a novel treatment strategy for luminal breast cancer.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 February 2014
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Inhibition of RET increases th ...... egy for luminal breast cancer.
@en
Inhibition of RET increases th ...... egy for luminal breast cancer.
@nl
type
label
Inhibition of RET increases th ...... egy for luminal breast cancer.
@en
Inhibition of RET increases th ...... egy for luminal breast cancer.
@nl
prefLabel
Inhibition of RET increases th ...... egy for luminal breast cancer.
@en
Inhibition of RET increases th ...... egy for luminal breast cancer.
@nl
P2093
P2860
P50
P1476
Inhibition of RET increases th ...... egy for luminal breast cancer.
@en
P2093
Alexandra Thomas
Anthony R Cyr
George W Woodfield
James P De Andrade
Jung-Min Park
Philip M Spanheimer
Ryan W Askeland
P2860
P304
P356
10.1158/1078-0432.CCR-13-2221
P407
P577
2014-02-13T00:00:00Z